Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Leuk Lymphoma. 2018 Feb 21;59(11):2686–2691. doi: 10.1080/10428194.2018.1439167

Table 1.

Patient and Disease Characteristics at Time of Diagnosis

Pt. # Age (years) SEX RAI staging B2M IgHv mutational status FISH ALC % of leukemia cells
1 60 Mal 4 9.6 UM Negative 15.13 73
2 64 F 2 4.4 M Negative 19.6 70
3 47 F 2 4.5 UM 17p 182 93
5 77 M 2 2.7 UM Negative 14.43 82
6 60 M 4 5.3 UM 11q,13q 26.28 93
7 43 M 3 2.2 UM Negative 38.5 89
8 60 M 3 3.8 ND 11q,13q 79 95
9 49 M 3 2.6 UM 17p,11q,13q 83.8 94
10 68 M 4 6.4 M 11q,13q 53 91
12 44 F 3 4 UM Negative 124 95
13 62 M 1 1.6 M 13q 8.81 52
14 65 M 0 2.3 M del13q 6.34 42
15 64 M 0 1.4 M T12 17.07 85
16 51 M 2 3.3 UM 11q,13q 24 80
17 66 M 2 4.1 UM 11q 158.3 93
18 54 M 2 2.2 UM 13q 124 92
19 60 M 4 9.6 UM Negative 15.13 72

Pt, patient; B2M, beta 2 microglobulin; IgHv, immunoglobulin heavy chain; FISH, Florescence in-situ hybridization; ALC absoloute lymphocyte counts; UM, unmutated; ND, not done; M, mutated;